BioAge Labs: BIOAGE is a VC-backed biotech company aimed at finding drugs that extend healthspan using machine learning and biomarkers to speed up the discovery process.
Social Links
What is BioAge Labs's Revenue?
BioAge Labs's estimated revenue for 2023 is $7M.
What does BioAge Labs do?
BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases. We've built a systems biology platform to map out the key molecular pathways that impact healthy human aging, based on proprietary human aging cohorts that have blood samples collected up to 45 years ago with participant -omics data that is tied to detailed medical follow-up records over their lifespan. To date, BioAge has raised $127M from Andreessen Horowitz, Kaiser Foundation Hospitals, and others. Recently, BioAge in-licensed our first two platform assets, and for both programs we'll be initiating Phase 2 efficacy trials by H1 2021. Our mission is to develop a pipeline of therapeutic assets that increase healthspan and lifespan. For additional information about BioAge, visit the company's website at www.bioagelabs.com
You May Also Find These Company Reviews Interesting
Meet glowforge, your at-home 3d laser printer that makes magical things at the push of a button. easily create custom products with a professional laser cutter.... More
Our clients trust us with $250m in paid advertising spend. we know what it takes to partner with you and get the results you need for your business to grow.... More